Clinical Trials Logo

Infant, Diabetic Mother clinical trials

View clinical trials related to Infant, Diabetic Mother.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT00994149 Not yet recruiting - Hypoglycemia Clinical Trials

Diazoxide In the Management Of Hypoglycemic Neonates

DIMOHN
Start date: October 2009
Phase: Phase 2/Phase 3
Study type: Interventional

Diazoxide is an oral hyperglycemic medication. Diazoxide has been proven effective for treating hypoglycemia in infants and children with some types of persistent hyperinsulinemic hypoglycemia. The mechanism of action results in decreased insulin secretion. One of the causes of hypoglycemia in infants of diabetic mothers occurs due to a transient hyperinsulinemic state postnatally. The investigators have clinical experience and success using diazoxide in their unit for patients with hypoglycemia not adequately managed with intravenous (iv) dextrose and enteral supplementation. In this randomized controlled study the investigators expect that by using diazoxide as the initial treatment for infants of diabetic mothers with asymptomatic hypoglycemia (blood glucose of 2.5 to 2.0mmol/L), the investigators will be able to decrease the number of infants requiring an intravenous by at least thirty percent.